Diseases, Conditions, Syndromes

Beginning of the end of hepatitis B in Australia?

(Medical Xpress)—A newborn vaccination program first introduced for Aboriginal babies in the Northern Territory has made significant inroads, significantly helping in the push to eradicate chronic hepatitis B infection ...

Medications

Bristol-Myers ends hepatitis C drug development

(AP)—Drugmaker Bristol-Myers Squibb Co. has scrapped a potential hepatitis C treatment after a patient participating in a test of the drug died of heart failure.

Medical research

Stem cells could drive hepatitis research forward

Hepatitis C, an infectious disease that can cause inflammation and organ failure, has different effects on different people. But no one is sure why some people are very susceptible to the infection, while others are resistant.

Medical research

Engineered, drug-secreting blood vessels reverse anemia in mice

Patients who rely on recombinant, protein-based drugs must often endure frequent injections, often several times a week, or intravenous therapy. Researchers at Children's Hospital Boston demonstrate the possibility that blood ...

Diseases, Conditions, Syndromes

Severe alcoholic hepatitis: An effective combination of two treatments

A French multi-center study has shown that a treatment combining an antioxidant with an anti-inflammatory was effective on 174 patients suffering from severe alcoholic hepatitis. The study was coordinated by the Hepato-Gastroenterology ...

page 7 from 9